| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Joshua A. Kazam | Director | Dec 18, 2025 | Option/RSU Exercise | - | 47,700 | - | 350,763 | Dec 22, 2025, 06:57 PM | |
| ALLO | Allogene Therapeutics, Inc. | Joshua A. Kazam | Director | Mar 07, 2022 | Gift | - | 412,618 | - | 258,885 | Mar 09, 2022, 06:26 PM | |
| ALLO | Allogene Therapeutics, Inc. | Joshua A. Kazam | Director | Jan 12, 2022 | Buy | $12.60 | 15,000 | 189,000 | 258,885 | Jan 14, 2022, 02:13 PM | |
| ALLO | Allogene Therapeutics, Inc. | Joshua A. Kazam | Director | Jun 11, 2021 | Gift | - | 500,000 | - | 243,885 | Jun 11, 2021, 05:43 PM | |
| ALLO | Allogene Therapeutics, Inc. | Joshua A. Kazam | Director | Nov 11, 2019 | Gift | - | 446,623 | - | 1,007,080 | Nov 21, 2019, 04:43 PM | |
| EAGL | Platinum Eagle Acquisition Corp. | Joshua A. Kazam | Director | Mar 05, 2019 | Buy | $10.20 | 5,000 | 51,000 | 10,000 | Mar 05, 2019, 05:42 PM | |
| EAGL | Platinum Eagle Acquisition Corp. | Joshua A. Kazam | Director | Mar 01, 2019 | Buy | $10.13 | 5,000 | 50,650 | 5,000 | Mar 01, 2019, 07:21 PM | |
| ALLO | Allogene Therapeutics, Inc. | Joshua A. Kazam | Director | Oct 15, 2018 | Conversion | - | 18,716 | - | 1,390,651 | Oct 17, 2018, 05:31 PM | |
| CAPR | CAPRICOR THERAPEUTICS, INC. | Joshua A. Kazam | Director | Jan 21, 2015 | Buy | $3.52 | 7,096 | 24,999 | 38,084 | Jan 22, 2015, 07:25 PM |